Details of the Drug Combinations

General Information of This Drug (ID: DMJFRCT)

Drug Name

Tasisulam DMJFRCT

Synonyms

Tasisulam sodium; LY-573636; LY-573636 sodium; LY-573636Na; Apoptosis stimulator (cancer), Lilly

Indication

Disease Entry	ICD 11	Status	REF
Acute myeloid leukaemia	2A60	Phase 3	[1]
------------------------------------------------------------------------------------

Drug Type

Small molecular drug

Structure

3D MOL

2D MOL

List of Combinatorial Drugs (CBD) Containing This Drug

7 Clinical Trial Drug Combination(s) Consisting of This drug

DrugCom Name	DrugCom ID	Component Drug	Indication	REF
Docetaxel + Tasisulam	DCT6QOI	Docetaxel	Advanced Solid Tumors	[2]
Erlotinib + Tasisulam	DC4YUJT	Erlotinib	Advanced Solid Tumors	[2]
Gemcitabine + Tasisulam	DCAEJWW	Gemcitabine	Advanced Solid Tumors	[2]
Tasisulam + Temozolomide	DC1663Y	Temozolomide	Advanced Solid Tumors	[2]
Tasisulam + Midazolam	DC3K89Y	Midazolam	Advanced Cancer	[3]
Tasisulam + Pemetrexed	DCEU2TE	Pemetrexed	Solid Tumors	[4]
Tolbutamide + Tasisulam	DCM4WII	Tolbutamide	Lymphoma	[5]
------------------------------------------------------------------------------------


⏷ Show the Full List of 7 DrugCom(s)

References

1	ClinicalTrials.gov (NCT01006252) A Study of Tasisulam Versus Paclitaxel as Treatment for Metastatic Melanoma. U.S. National Institutes of Health.
2	ClinicalTrials.gov (NCT01284335) A Safety Study in Participants With Advanced Solid Tumors
3	ClinicalTrials.gov (NCT01209832) A Tasisulam and Midazolam Drug Interaction Study in Cancer Patients
4	ClinicalTrials.gov (NCT01215916) A Phase 1 Study in Patients With Solid Tumors
5	ClinicalTrials.gov (NCT01185548) A Drug Interaction Study of Tasisulam in Patients With Advanced Cancer or Lymphoma